Back to Research Hub
Amphastar Pharmaceuticals, Inc.
AMPH
$20.16+0.77 (+3.97%)
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API.
StreetsValue research for Amphastar Pharmaceuticals, Inc. (AMPH)
Members get the full report for Amphastar Pharmaceuticals, Inc.: a fair value estimate and valuation analysis, economic moat rating, growth and profitability factor grades, a bull and bear investment thesis, analyst price targets, insider and congressional trading activity, and which super investors own the stock.